Steril-Gene Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 216.00 Cr
- Paid Up Capital ₹ 212.64 Cr
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 339.75 Cr
- Satisfied Charges ₹ 148.02 Cr
- Revenue Growth 22.75%
- Profit Growth 2.26%
- Ebitda 34.88%
- Net Worth 67.40%
- Total Assets 18.65%
About Steril-Gene Life Sciences
Steril-Gene Life Sciences Private Limited (SLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 February 2007 and has a history of 17 years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Sterigene Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 216.00 Cr and a paid-up capital of Rs 212.64 Cr.
The company currently has active open charges totaling ₹339.75 Cr. The company has closed loans amounting to ₹148.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Steril-Gene Life Sciences Private Limited India is Pabitti Manjulatha as COMPANY SECRETARY. Sulaiman Mohammed, Zenaida Balajadia, Lloyd Balajadia, and Eight other members serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U02423TN2007PTC062549
-
Company No.
062549
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Feb 2007
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Steril-Gene Life Sciences Private Limited offer?
Steril-Gene Life Sciences Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Pain Relief Spray.
Who are the key members and board of directors at Steril-Gene Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sulaiman Mohammed
|
Managing Director | 28-Feb-2007 | Current |
|
Pabitti Manjulatha
|
Company Secretary | 01-Nov-2019 | Current |
Board Members (10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Vijay Balakumar
|
Additional Director | 14-Dec-2023 | Current |
Lloyd Balajadia
|
Director | 04-Dec-2009 | Current |
|
Dick Balajadia
|
Director | 04-Dec-2009 | Current |
|
Dennis Balajadia
|
Director | 04-Dec-2009 | Current |
|
Zenaida Balajadia
|
Director | 04-Dec-2009 | Current |
|
Maximo Balajadia
|
Director | 04-Dec-2009 | Current |
Financial Performance of Steril-Gene Life Sciences.
Steril-Gene Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.75% increase. The company also saw a slight improvement in profitability, with a 2.26% increase in profit. The company's net worth Soared by an impressive increase of 67.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Steril-Gene Life Sciences?
In 2022, Steril-Gene Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Madras Pharmaceuticals Private LimitedSulaiman Mohammed, Alagappan and 1 more are mutual person
-
Dr Humayun Speciality Hospital Private LimitedSulaiman Mohammed is a mutual person
-
International Ingredients & Excipients Private LimitedZenaida Balajadia and Lloyd Balajadia are mutual person
-
Softgel Healthcare Private LimitedSulaiman Mohammed is a mutual person
-
Anphar Organics Private Limited.Sulaiman Mohammed, Alagappan and 1 more are mutual person
-
Maral Health Care Private Limited
Sulaiman Mohammed, Alagappan and 1 more are mutual person
Charges (Loans)
₹339.75 Cr
₹148.02 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 339.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 May 2024 | Hdfc Bank Limited | ₹30.00 Cr | Open |
| 09 Jun 2023 | Hdfc Bank Limited | ₹120.00 Cr | Open |
| 17 Apr 2023 | Hdfc Bank Limited | ₹9.00 Cr | Open |
| 17 Apr 2023 | Hdfc Bank Limited | ₹5.00 Cr | Open |
| 08 Sep 2021 | Hdfc Bank Limited | ₹20.00 Cr | Open |
How Many Employees Work at Steril-Gene Life Sciences?
Steril-Gene Life Sciences has a workforce of 957 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Steril-Gene Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Steril-Gene Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
